Viveve Medical IncOver The Counter Market:VIVE
- LAST PRICE0.0002
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0002 / 0.0002
- Day Range
- 52 Week Range
- Volume1,404
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIVE |
|---|---|---|
| 10:28 ET | 804 | 0.0002 |
| 02:54 ET | 600 | 0.0002 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Viveve Medical Inc | 2.1K | 0.0x | --- |
HTG Molecular Diagnostics Inc | 3.3K | 0.0x | --- |
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
G Medical Innovations Holdings Ltd | 489.3K | 0.0x | --- |
Leafbuyer Technologies Inc | 2.7M | -2.8x | --- |
Arrayit Corp | 750.0 | 0.0x | --- |
Company Information
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.
Contact Information
- Headquarters
- 345 Inverness Drive South Building B, Suite 250ENGLEWOOD, CO, United States 80112
- Phone
- 408-530-1900
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Steven Basta
- Chief Executive Officer, Director
- Scott Durbin
- Senior Vice President - Finance and Administration
- Jim Robbins
- Independent Director
- Deborah Jorn
- Independent Director
- Arlene Morris
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1K |
|---|---|
Revenue (TTM) | $6.8M |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.09 |
EPS | $-2.65 |
Book Value | $1.42 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -316.39% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
